Related Experiment Video
Updated: Mar 28, 2026
10:11
Immunohistochemical Staining of B7-H1 PD-L1 on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue
Published on: January 3, 2013
23.7K
[Research Progress on Co-stimulating Molecule B7-H3 in Hematological Malignancies]
Wei Zhang1, Jing Wang1, Xiao-Yan Ke1
1Department of Hematology, Peking University Third Hospital, Beijing 100191, China.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|December 29, 2015
Summary
B7-H3, a costimulatory molecule, is overexpressed in hematologic malignancies, correlating with disease progression and poor prognosis. Targeting B7-H3 presents a promising therapeutic strategy for these cancers.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- B7-H3 is a costimulatory molecule with complex immunoregulatory roles.
- While B7-H3 mRNA is widespread, protein expression is limited in normal tissues.
- Aberrant B7-H3 overexpression is linked to solid tumors and poor prognosis.
Purpose of the Study:
- To review the role of B7-H3 in hematologic malignancies.
- To explore B7-H3 as a diagnostic marker and therapeutic target in these cancers.
Main Methods:
- Literature review of studies on B7-H3 and hematologic malignancies.
- Analysis of B7-H3 expression patterns and clinical associations.
Main Results:
- B7-H3 overexpression is significantly associated with malignancy grade, relapse, progression, and prognosis in hematologic malignancies.
- B7-H3 also performs non-immunological functions in oncogenesis.
- Immunotherapy targeting B7-H3 is a rapidly developing research area.
Conclusions:
- B7-H3 is a potential diagnostic marker for hematologic malignancies.
- Targeting B7-H3 offers a promising therapeutic avenue for these cancers.
- Further research into B7-H3 immunotherapy is warranted.
Related Concept Videos
01:01Regulation of Hematopoietic Stem Cells
4.4K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.4K
01:28Role of Hematopoietic Growth Factors
4.3K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
4.3K
01:24B Cell Activation and Differentiation
18.0K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
18.0K
01:15Differentiation of Common Myeloid Progenitor Cells
4.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.2K
01:19Multipotency of Hematopoietic Stem Cells
4.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
4.1K
01:21Hematopoiesis
9.8K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
9.8K